Title : A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.

Pub. Date : 2006 Dec

PMID : 17087947






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We conducted a randomized, placebo-controlled, double-blind trial to assess whether use of the selective COX-2 inhibitor rofecoxib would reduce the risk of colorectal adenomas. rofecoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens